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The American Thoracic Society (ATS) and the European Respiratory Society (ERS) recommend that the largest 
forced vital capacity (FVC) and the largest forced expiratory volume in 1 s (FEV,) should be recorded from at least 
three acceptable curves independently which curve they came from. Although these recommendations have been 
used for decades, there is still some controversy over their validity. 
The purpose of this study was to determine how the intersession variability of reported FVC and FEV, values is 
influenced by different methods of selection in clinical practice. 
The study population consisted of 283 patients with obstructive airway diseases. Spirometry was performed until 
three acceptable forced expiratory curves were obtained in the standing position. A second set of spirometric 
measurements was obtained approximately 30 min after the first set of measurements. The following sampling 
methods were compared: method A, the largest FVC and the largest FEV, among all three acceptable curves 
(ATS-ERS recommendation); method B, the FVC and the FEV, from the single curve that yielded the largest sum 
of FVC plus FEV, (best test); method C, the average of all three acceptable curves; method D, the average of the 
largest two FVCs and FEV,s among all of the three acceptable curves. 
FVC and FEV, determined by method B gave almost identical values to those obtained by method A in most 
cases. However, method A was least variable for FEV,. In addition, the differences in FEV, values between these 
two methods were large in some of patients with chronic obstructive pulmonary disease. The other selection criteria 
compared in this study offer no clear-cut advantages over method A. 
The ATSERS recommended method appeared to be slightly more reproducible than the other selection criteria, 
including the ‘best test’ method, and should therefore be the preferred method of choice. 
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Introduction 
The American Thoracic Society (ATS) (1,2) and the 
European Respiratory Society (ERS) (3) recommend that, 
in the reporting of spirometric results, the largest forced 
vital capacity (FVC) and the largest forced expiratory 
volume in 1 s (FEV,) should be selected from data obtained 
from at least three acceptable forced expiratory curves, even 
if these values are not obtained from the same curve. 
Sorensen and coworkers showed that FVC and FEV, 
obtained from the ‘best test’ did not differ much from 
values based on the ATS-ERS recommendation and 
suggested that the selection of values from the single ‘best 
test’ would be simpler and more practical approach (4). 
The Committee on Proficiency Standards for Clinical 
Pulmonary Function Laboratories of ATS has continued to 
use their recommended procedure because a large database 
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has been collected under current recommendations and the 
differences between the two methods are insignificant. Also, 
FVC and FEVi are independent values and may be selected 
from different curves with the largest values representing 
the subject’s highest potential values. Therefore the 
ATS-ERS recommendation is currently the procedure of 
choice for legal and regulatory purposes (1). However, from 
a medical point of view the selection method of choice 
should provide the most reproducible recordings across a 
wide range of respiratory impairment. Recently, Wise and 
associates reported that several methods, including the 
current recommended method, provided similar and 
satisfactory reproducibility in smokers with mild to moder- 
ate chronic airflow obstruction among the population 
taking part in the Lung Health Study and concluded that 
there was no reason to change the currently recommended 
selection methods for FEV, and FVC (5). However, it is 
still unknown whether these observations are also valid in 
patients who have more severe airflow limitations. The 
present prospective study was designed to evaluate how the 
intersession variability of reported FVC and FEV, values is 
influenced by different selection methods in patients with 
various obstructive pulmonary diseases. 
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TABLE 1. Patient characteristics (mean f SD) 
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Fl 
Age FVC (1) 
(years) (% predicted) 
FEV, (1) 
(% predicted) 
Asthma Male 74 45.6 f 16.5 3.61 f 0.88 2.70 f 0.88 
(88.7 zt 14.5) (808 f 18.0) 
Female 48 48.5 z!z 17.3 2.48 i 0.50 1.99 ZIZ 0.52 
(88.7 f 13.6) (86.8 zt 16.2) 
COPD Male 123 67.4 f 7.2 2.42 f 0.77 1.23 f 0.58 
(71.3 + 20.4) (47.4 f 20.5) 
Female 4 60.0 k 13.9 1.52 k 0.52 0.85 k 0.45 
(59.8 f 22.4) (440 h 26.7) 
DPB Male 20 47.9 f 17.5 3.25 f 0.96 2.39 f 1.09 
(80.6 * 20.2) (71.4 f 27.0) 
Female 14 60.0 ic IO.8 1.66 L!Z 0.60 1.06 f 0.46 
(63.0 f 20.6) (51.2 I!Z 20.5) 
TABLE 2. The mean FEV, and FVC of each forced expiratory curve (mean f SD) 
1st 
Session 1 
2nd 3rd 1st 
Session 2 
2nd 3rd 
FVC (1) All 2.66 ck 0.93 2.69 * 0.97 2.70 f 0.97 2.68 zt 0.96* 2.70 z!z 0.97 2.70 rt 0.96 
Asthma 3,08 f 0.93 3.11 f 0.95 3.11 f 0.93 3.08 k 0.93* 3.10 f 0.93 3.09 f 0.93* 
COPD 2.30 f 078 2.32 f 0.77 2.34 zt 0.79 2.32 f 0.79 2.34 k 0.79 2.36 ct 0.80 
DPB 2.52 f 1.13 2.54 f 1.12 2.57 f 1.15 2.56 * 1.15 2.58 f. 1.15 2.57 it 1.15 
FEV, CL) All 1.75 f 0.93 1.77 z!c 0.95 1.79 f 0.95 1.78 & 0.95* 1.80 z!z 0.95 1.80 ct 0.95 
Asthma 2.34 k 0.82 2.38 zk 0.83 2.40 f 0.83 2.38 ho.83 2.38 f 0.84 2.39 f 0.84 
COPD 1.17 Lt 0.57 1.19 f 0.57 1.20 & 0.58 1.20 k 0.58 1.22 f 0.58? 1.22 f 0.587 
DPB 1.77 + 1.08 1.80 f 1.09 1.82 * 1.10 1.80 f 1.12 I.844 1.11 1.85 f 1.127 
*Significantly smaller than the third measurement of session 1. tSignificantly larger than the third measurement of session 1. 
Subjects and Methods 
SUBJECTS 
The study population consisted of 122 patients with asthma 
(male:female=74:48), 127 patients with chronic obstructive 
pulmonary disease (COPD; male:female= 123:4), and 34 
patients with diffuse panbronchiolitis (DPB; male: 
female=20:14), who visited the Chest Disease Research 
Institute Hospital, Kyoto University, from December 1992 
to March 1994. Baseline characteristics are summarized in 
Table 1. 
The diagnosis of asthma was based on the clinical 
presentation of asthma symptoms and the documentation 
of increased bronchial responsiveness to methacholine at 
least once during the clinical course of illness in almost all 
of the patients. Most of the patients were under inhaled 
beclomethasone dipropionate treatment. The diagnosis of 
COPD was based on the definition of the ATS (6). The 
patients with COPD in the present study fulfilled the 
following criteria: (1) a maximum ratio of FEV, to FVC of 
less than 70% over several measurements of postbroncho- 
dilator spirometry; (2) a smoking history of greater than 
20 pack-years; (3) no history cansistent with asthma such 
as paroxysmal dypnoea or wheezing. The diagnosis of DPB 
was made according to the clinical diagnostic guidelines 
established for DPB in the nationwide survey by the Health 
and Welfare Ministry of Japan. In addition, chronic 
paranasal sinusitis and centrilobular nodules (7) found in 
computed tomography were confirmed in all patients with 
DPB. 
Informed consent was obtained from all participants. 
Methods 
Initially, spirometry was performed with an AS-600 
Spirometer, a hot-wire anemometer (8) (Minato Medical 
Equipment Co, Tokyo, Japan) with 10 ml volume resolu- 
tion, until three acceptable forced expiratory curves were 
obtained in the standing position (session 1). An acceptable 
manoeuvre was defined as one without hesitation or cough- 
ing, with at least 6 s of expiration, and a back-extrapolated 
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FIG. 1. Cumulative histograms of absolute differences, in (a) FVC and (b) FEV,: Li, method A; 0, method B: 
C; 0, method D. Abscissa, cumulative number of cases; ordinate, absolute difference between session 1 and session 2 (ml). 
volume of less than 5% of the FVC or 0.15 1, whichever was 
greater. 
After resting for 34 min in a sitting position, each 
subject blew in the standing position into four portable 
peak flow meters three times for each in a random order, 
with intervals of 334 min between measurements. These 
procedures were done in order to compare the readings of 
various portable peak flow meters, the results of which 
are not addressed in this article. Thereafter, the second 
spirometric measurements were obtained until three accept- 
able.forced expiratory curves were obtained in the standing 
position (session 2). This second set of measurements was 
taken about 30 min after session 1. All measurements 
were conducted by chest physicians (AI. and H.K.). The 
spirometer was calibrated every morning with a 3 1 syringe. 
Inhalations of B-receptor agonists or anticholinergic drugs 
were withheld for at least 12 h before spirometric measure- 
ments were taken. Up to five procedures were performed 
until the reproducibility criteria were met for each session. 
No data were excluded from the analysis on the basis of 
reproducibility criteria. 
The FVC and FEV, values obtained from the following 
two sampling methods were compared: method A, the 
largest FVC and the largest FEV, among all of three 
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acceptable curves (ATS-ERS recommendation); method B, 
the FVC and FEV, from the single curve that yields the 
largest sum of FVC plus FEV, (best test); method C, 
the average of all three acceptable curves; method D, the 
average of the largest two FVCs and FEV,s among all of 
the three acceptable curves. 
Statistics 
The paired t test was used for the analysis of variables with 
normal distribution. The Friedman ANOVA and Wilcoxon 
matched-pair test or Kruskal-Wallis ANOVA and Mann- 
Whitney U test were used as non-parametric methods; 
PcO.05 was accepted as significant. 
Results 
The mean FVC and FEV, for each forced expiratory curve 
are shown in Table 2. FEV, and FVC reached a plateau in 
session 1 and there was no significant difference between the 
last curve of session 1 and the last two curves of session 2. 
However, when these data were broke down by disease 
category, the FEV, values from the last two curves in 
session 2 were significantly larger than FEV, from the last 
curve of session 1 in patients with COPD. 
COMPARISON BETWEEN SESSION 1 AND 
SESSION 2 
Cumulative histograms of absolute differences in FVC and 
FEV, between session 1 and session 2 (Fig. 1) showed that 
method A was most reproducible for FEV, followed by 
methods B and D, with method C being least reproducible. 
The distribution of absolute differences in FEV, between 
session 1 and session 2 for each disease category is shown 
in Fig. 2. Although no apparent differences were observed 
for FEV, when analysed on the basis of absolute value 
(Friedman ANOVA, P=O.437) between any of the methods 
studied here, method A produced a smaller absolute differ- 
ence relative to baseline FEV, than method B (Friedman 
ANOVA, P=O.O338, and Wilcoxon matched pairs test, 
P=O.O479). The absolute difference in FEV, values between 
sessions 1 and 2 was less than 50ml in 196 (69.3%) 190 
(67.1%), 178 (62.9%) and 185 (65.4%) cases using methods 
A, B, C and D, respectively. 
On average FVC was larger in session 2 than session 1 by 
1 rt 108, 2& 110, 7& 100 and 5 & lOOm1, as was FEV, by 
18 f 65, 16 & 67, 21 & 64 and 21 * 62 ml, when determined 
by methods A, B, C and D, respectively. The means of these 
differences were not significantly different between any of 
the four methods (paired t test). However, the variances of 
the differences in FEV, were significantly smaller than those 
of FVC (Bartlett test of homogeneity of variance, P<O.OOl 
for each selection method). 
The reproducibility of manoeuvres in session 1 was not 
significantly correlated with the reproducibility in session 2, 
for both FVC and FEVi (Fig. 3), when reproducibility was 
determined as the difference between the largest and the 
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FIG. 2. Distribution of (a) absolute differences and (b) 
absolute differences as percentages of baseline in FEV,: 
n , method A; A, method B; 4, method C; 0, method D. 
COMPARISON BETWEEN METHOD A AND 
OTHER METHODS IN SESSION 1 
Since the ATS-ERS recommendation is the most widely 
accepted method, we examined the differences between 
method A and the other methods. The mean differences in 
FVC in session 1 between method A and other methods 
were 3.3, 66.4 and 30.1 ml for methods B, C and D, 
respectively. For FEV,, the differences were 4.9, 41.8 and 
1.5 ml, respectively. 
In comparison with method A, sampling by method B 
underestimated FEV, by only 4.9ml and FVC by only 
3.3 ml in session 1. However, the mean differences between 
FEV, values determined by methods A (FEV,-A) and B 
(FEV,-B) were statistically larger in patients with COPD 
(8 ml) than in those with stable asthma or DPB (2 ml for 
both) (Kruskal-Wallis ANOVA, P=O.O12, and Mann- 
Whitney U test, P=O.O052 for COPD vs. asthma). As 
shown in Fig. 4, FEV, determined from the ‘best test’ curve 
differed considerably from that determined by method A in 
some of the patients with COPD. The difference between 
FEV,-A and FEV,-B in session 1 was greater than 50 ml in 
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FIG. 3. Reproducibility of (a) FVC and (b) FEV, at session 1 and session 2, measured as the difference between the 
largest and second largest values. 
four patients, all of whom were COPD patients. There was Discussion 
no significant difference between FVC-A and FVC-B, 
regardless of disease type. Only two male subjects (one male 
asthmatic and one male COPD patient) had a difference 
greater than 50 ml between FVC-A and FVC-B. The differ- 
ences in FVC and FEV, between method A and method 
C or D were much larger than those between methods A 
and B. 
In the present study we showed that method A was most 
reproducible for FEV,, followed by methods B and D. 
Method C (mean value of all three recorded curves) was 
least reproducible. For FVC, method D or C appeared to 
be more reproducible than method A or B, suggesting that 
in patients with severe airllow obstruction, FVC values, 
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FIG. 4. Differences in FEV, between method A and other 
methods: n , A-B; A, A-C; 4, A-D. 
depending on the duration of expiration, are less reproduc- 
ible and that averaging more than one record could reduce 
the variability. Ullah and associates conducted a study in 
which 105 subjects performed lo-20 sets of spirometric 
measurements and found that the values showed a normal 
distribution, suggesting that the true value is probably the 
mean of as many observations as can be obtained con- 
veniently (9). Nathan and coworkers compared several 
criteria for selection of the best FEV, and FVC from five 
spirograms in a general population studied repeatedly over 
a period of 3 yr (10). They found that, although mean 
percentage differences in FEV, between years were smaller 
in the averages of the highest values than in the best values, 
the standard deviations were not statistically different 
between any given comparisons, leading them to conclude 
that there was little to be gained by using values other than 
the largest values. On the other hand, in the study of Wise 
et al. the variability in FVC and FEV,, which was calcu- 
lated as the mean of all records, was among the highest in 
the selection methods they compared (5). On balance, 
perhaps the difference in reproducibility between the value 
derived from a single curve or the average of more than one 
might be quite small. Therefore, there would be no reason 
to choose another method over the recommended method. 
In addition, finding the largest FVC and the largest FEV, 
can be easier than selecting the ‘best test’ or averaging mote 
than one value, in the absence of dedicated software. 
Sampling from the single ‘best test’ was shown to give 
almost equivalent FVC and FEV, values to those derived 
by the ATS-ERS recommended method in patients with the 
various respiratory diseases described in the present study. 
This observation is compatible with the previous report by 
Sorensen and associates that revealed the average difference 
between the two methods to be very small (4). However, the 
differences in FEV, between values obtained from the ‘best 
test’ curve and those obtained by the ATS-ERS recom- 
mended method were larger in patients with COPD. The 
absolute values of these differences were generally quite 
small and often below the reproducibility criteria of the 
spirometer (50 ml or 3%). However, a few patients with 
COPD have a difference of more than 50 ml between 
FEV,-A and FEV,-B. Combined with the observed larger 
variability obtained by method B between sessions 1 and 2, 
the ATS-ERS recommended method would seem to be the 
preferred procedure. This is particularly true in cases of 
COPD where values in epidemiological or pharmacological 
studies often involve small changes in spirometric values. 
At least, the mixing of values obtained by different methods 
should be avoided in such situations as multicentre studies. 
The other two methods compared in this study were 
even more different from method A than method B and 
offered no clear-cut advantages over method A in terms of 
reproducibility. 
Finally, FEV, and FVC reached a plateau at the third 
measurement of session 1, confirming that at least three 
forced expiratory curves were needed to ensure reproduc- 
ibility. In addition, FEV, obtained from the third curve of 
session 1 was, on average, equivalent to that obtained from 
session 2, indicating that sampling from three acceptable 
curves yielded satisfactory reproducibility. However, the 
FEV, values obtained from the last two curves of session 2 
were significantly larger than that of the last value obtained 
in session 1 in patients with COPD. This observation 
suggested that more than three forced expiratory curves 
could produce an even greater value than the recommended 
method, in patients with COPD. This finding is consistent 
with the observation of Pennock et al., which showed a 
greater coefficient of variation in chronically obstructed 
subjects (1 l), with eight manoeuvres being demonstrated to 
be the practical upper limit (12). However, we did not 
address whether increasing the number of examinations 
would result in better reproducibility in patients with 
COPD in the present study. 
There has been some controversy over how many 
spirograms are enough for the measurement of FEV, and 
FVC. Ferris et al. recommended a minimum of five, with no 
more than eight in their laboratory and field studies (12). 
Freedman and Prowse suggested that, for clinical purposes, 
three forced expirations would usually prove adequate for 
the measurement of FEV, (13). Nathan et ul. also con- 
cluded that there is little to be gained by requiring more 
than three manoeuvres (10). On the other hand, Ullah et al. 
suggested the mean of as many observations as can be 
conveniently obtained should provide the best estimate of 
the true value (9). Although we do not address this problem 
in the present study, probably three to six tests would be 
enough in the usual circumstances. Freedman and Prowse 
also reported that ‘experienced’ patients who had pre- 
viously undergone spirometric tests were different from the 
‘inexperienced’ in that a significantly greater number of the 
experienced subjects reached their peak FEV, in their first 
expiration (13). In this regard. subjects in the present study 
were all familiar with the spirometric tests and this might 
have contributed to the observed small difference between 
session 1 and session 2 with 12 forced blows into peak flow 
meters in between. Spirometry-induced bronchospasm is 
known to occur in some patients with asthma or other 
reactive airway diseases. This problem could potentially 
complicate the data analysis, in addition to possible com- 
plication due to fatigue in some of the chronically ill 
patients. However, these problems were, on the whole, not 
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apparent in this study, probably because of adequate 
treatment with inhaled corticosteroids in patients with 
asthma. 
In conclusion, the currently recommended method 
appears to be slightly more reproducible for FEV, than any 
other methods examined in this study and should therefore 
be the preferred method of choice. 
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